September 10, 2009 11:19 AM
- Text
AGP to Probe Undisclosed Industry Ties of Doc Who Recommends Antidepressants for 3-Year-Olds
(MoneyWatch) The journal Archives of General Psychiatry will "look into" whether an author who recommended antidepressants for preschoolers failed to disclose her financial ties to Johnson & Johnson, AstraZeneca and Shire, companies which make such drugs, according to Philip Dawdy of Furious Seasons.
Dr. Joan Luby, a professor of child psychiatry at the Washington University School of Medicine in St. Louis, has authored several papers asserting that children as young as three years old can suffer from depression and bipolar disorder, and that treatment with antidepressants and antipyschotics may be appropriate. In a recent paper for the AGP, she wrote:
Dawdy points out that a typical disclosure period is five years -- meaning authors must disclose financial relationships going back that far. Luby was funded by Shire and AZ in 2004.
BNET readers first learned of Luby in August, when we noted that in 2007 Luby authored two papers in the Journal of Child and Adolesent Psychopharmacology (one on pyschotropic prescriptions in preschoolers and another urging the "responsible" treatment of young people with medications). Neither of those papers disclosed her industry ties, even though Luby authored a 2006 article in the Journal of the American Academy of Child & Adolescent Psychiatry, also about depression in preschoolers, which disclosed ties to the three companies.
Dr. Joan Luby, a professor of child psychiatry at the Washington University School of Medicine in St. Louis, has authored several papers asserting that children as young as three years old can suffer from depression and bipolar disorder, and that treatment with antidepressants and antipyschotics may be appropriate. In a recent paper for the AGP, she wrote:
Preschool depression, similar to childhood depression, is not a developmentally transient syndrome but rather shows chronicity and/or recurrence.She did not disclose any ties to industry. However, Luby has past ties to J&J's Janssen unit, AZ and Shire (makers of Risperdal, Seroquel and Adderall XR, respectively).
Dawdy points out that a typical disclosure period is five years -- meaning authors must disclose financial relationships going back that far. Luby was funded by Shire and AZ in 2004.
BNET readers first learned of Luby in August, when we noted that in 2007 Luby authored two papers in the Journal of Child and Adolesent Psychopharmacology (one on pyschotropic prescriptions in preschoolers and another urging the "responsible" treatment of young people with medications). Neither of those papers disclosed her industry ties, even though Luby authored a 2006 article in the Journal of the American Academy of Child & Adolescent Psychiatry, also about depression in preschoolers, which disclosed ties to the three companies.
Latest Now in MoneyWatch
- Gas prices continue to creep up
- Joe Coffee | Secrets of Successful Startups
- Small business mistake: coasting on past success
- Groupon's revenue, losses grow quarter to quarter
- News Corp beats estimates despite hacking charges
- Cisco earnings, sales top estimates
- Groupon reports loss, higher revenue
- BlackBerry apps more lucrative than iPhone?
- Chinese-born American acquitted of espionage
- Why coffee geeks make good employees
- The silent killer: Your In box
- Gary Busey files for bankruptcy
- Drugmaker pays $442m in Plavix patent case
- The 10 cheapest cars to insure
- The 10 priciest cars to insure
- Many small business owners favor "Buffett rule"
- Jeremy Grantham's investing strategies for 2012
Latest CBS News Headlines
on Facebook
on CBS News
- Asia stocks fall as Chinese inflation heats up
- Romanian accused of hacking NASA-JPL computers
- ICE's net income up 28 percent in Q4
- China's inflation rebounds in January to 4.5 pct
on Facebook
- Calif. surfer runs fastest-growing camera company
- Americans getting too much sodium, but not from salty snacks
- Mo. teen gets life in prison for murder of 9-year-old girl
on CBS News
